Century Therapeutics Inc (IPSC) experienced a significant stock price surge of 20.74% on Wednesday, reaching $1.63 per share, its highest single-day jump in over 11 months. This surge follows Casdin Capital’s acquisition of an additional 1.38 million shares, increasing their stake in the biotechnology company by 43%. The investment highlights Casdin Capital’s confidence in Century Therapeutics’ future.